Israel-based imaging vendor Nanox postpones investor day amid ongoing conflict in home country
Israel-based imaging vendor Nanox is postponing its upcoming investor day amid ongoing conflict in its home country, leaders announced Tuesday.
The publicly traded company had planned the event for Oct. 17 at the Nasdaq in New York City. However, Nanox will push back the occasion until a to-be-determined date as tensions continue to escalate in Israel.
“It is with sadness that we announce the decision to postpone our investor day,” CEO Erez Meltzer said in a statement issued Oct. 10. “We carefully made this decision in light of the horrifying recent events unfolding in Israel as an act of solidarity. Our business, in particular our U.S. operations and go-to-market strategy continue as planned, and Nanox employees are working safely as we continue to monitor and adapt to the evolving situation. We will continue to monitor the situation and provide updates as necessary.”
Nanox plans to announce a makeup date in the coming weeks. The Neve Ilan, Israel-based company was recently in the news after reaching a $1 million settlement with the SEC over allegations that it misrepresented how much it would cost to manufacture its flagship device.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.